Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Newly discovered thrombin inhibitors patented by Merck

March 21, 2003

Novel platelet ADP receptor inhibitors in Millennium development pipeline

March 21, 2003

New alpha2beta1 integrin antagonists identified at Ajinomoto

March 18, 2003

Bayer researchers describe novel series of selective factor Xa inhibitors

March 18, 2003

Catalyst Pharmaceutical will seek licenses for NM-702

March 13, 2003

Merck presents new antithrombotic thrombin receptor antagonists

March 13, 2003

Lilly researchers claim piperidine-containing factor Xa inhibitors

March 13, 2003

New factor Xa inhibitors in early development at Bayer

March 10, 2003

Argatroban meets primary endpoints in ARGIS-I study

March 7, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...